These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3300531)

  • 21. Nalidixic acid inhibits the conjugal transfer of conjugative N incompatibility group plasmids.
    Gill S; Iyer VN
    Can J Microbiol; 1982 Feb; 28(2):256-8. PubMed ID: 7039791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Ridgway GL; O'Hare MD; Felmingham D; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):259-62. PubMed ID: 2941258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Distribution and diversity of conjugative plasmids among some multiple antibiotic resistant E.coli strains isolated from river waters].
    Cernat R; Lazăr V; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):147-53. PubMed ID: 15085604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of the SOS response by new 4-quinolones.
    Phillips I; Culebras E; Moreno F; Baquero F
    J Antimicrob Chemother; 1987 Nov; 20(5):631-8. PubMed ID: 3323160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin.
    Zeiler HJ
    Drugs Exp Clin Res; 1985; 11(5):335-8. PubMed ID: 2941261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnr.
    Wang M; Sahm DF; Jacoby GA; Zhang Y; Hooper DC
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1400-1. PubMed ID: 15047552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro evaluation of A-56619 and A-56620, two new quinolones.
    Barry AL; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1986 Jan; 29(1):40-3. PubMed ID: 2942099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-level quinolone resistance amongst clinical isolates of Escherichia coli and Klebsiella pneumoniae from Spain.
    Alarcón T; Pita J; López-Brea M; Piddock LJ
    J Antimicrob Chemother; 1993 Oct; 32(4):605-9. PubMed ID: 8288502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
    Digranes A; Dibb WL; Benonisen E
    Chemotherapy; 1985; 31(6):466-71. PubMed ID: 2934234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance and conjugative R plasmids in Escherichia coli strains isolated from animals in Peninsular Malaysia.
    Koh CL; Kok CH
    Southeast Asian J Trop Med Public Health; 1984 Mar; 15(1):37-43. PubMed ID: 6377513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic transfer of antimicrobial resistance and enterotoxigenicity among Escherichia coli strains.
    Wachsmuth K; DeBoy J; Birkness K; Sack D; Wells J
    Antimicrob Agents Chemother; 1983 Feb; 23(2):278-83. PubMed ID: 6340604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinolones in vitro.
    Willems FT
    Pharm Weekbl Sci; 1986 Feb; 8(1):26-8. PubMed ID: 3960690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. R-plasmid transfer frequencies from environmental isolates of Escherichia coli to laboratory and fecal strains.
    Shaw DR; Cabelli VJ
    Appl Environ Microbiol; 1980 Oct; 40(4):756-64. PubMed ID: 6999996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].
    Grimm H
    Infection; 1986; 14 Suppl 3():S191-5. PubMed ID: 3093387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Obana Y; Nishino T
    Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfer Potential of Plasmids Conferring Extended-Spectrum-Cephalosporin Resistance in Escherichia coli from Poultry.
    Mo SS; Sunde M; Ilag HK; Langsrud S; Heir E
    Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411217
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.
    Smith SM
    Antimicrob Agents Chemother; 1986 Feb; 29(2):325-6. PubMed ID: 2940966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.
    Van der Auwera P
    Infection; 1986; 14(3):142-4. PubMed ID: 2942489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.